Those facilities likely will not be in the U.S., according to the officials, but in Europe. Nearly three dozen public-health officers have been deployed to Kenya to staff the quarantine and isolation units, some of them who served in West Africa during the 2014 Ebola outbreak.
The officials said the facilities will be supplied with the latest monoclonal antibody treatments, as well as the antiviral drug remdesivir and respiratory and hydration services to support patients who develop the disease.
But some public-health officials criticized the decision to triage in Africa and rely on European centers for more advanced care of exposed or sick American citizens. Dr. Ronald Nahass, president of the Infectious Disease Society of America, said in a statement that the strategy is “deeply concerning” and “raises serious questions about resources, timing and the level of care Americans sent there will receive.” Other health leaders agreed, expressing doubt that the level of care provided by deployed health professionals, in a temporary facility, could match that provided by experts in the U.S. at facilities there.
Read the full article here
